The Role of Copper Ions in Mediating the Anti‐Cancer Effects Using Nanomaterials
- 3 February 2025
- journal article
- Published by Wiley in Advanced Therapeutics
- Vol. 8 (3)
Abstract
Copper plays a pivotal role in human physiology, particularly in oncology, acting both as a facilitator of progression and also as a potential avenue for advanced therapeutic approaches. Maintaining copper homeostasis is crucial. The dysregulation of copper homeostasis is implicated in tumor growth through its involvement in critical processes of angiogenesis, proliferation, and metastasis. The elevation in copper level in the tumor microenvironment (TME) activates oncogenic pathways to drive the neovascularization and sustained growth of malignancies. However, the same reliance on copper offers a unique weakness that can be leveraged for innovative therapeutic interventions. The recent advances in nanomedicine enable the synthesis of nanostructures that can help modulate the level of copper with precision offering multifaceted approaches for copper‐based cancer therapy with controlled release mechanism, optimized structures to induce cuproptosis, selective eradication of cancer cells with minimum and systemic toxicity. This review explores the dual role of copper in cancer biology, emphasizing its contribution to the progression of tumors and its emerging application in targeted cancer therapy. The review also highlights the potential of nanostructures in harnessing copper‐based therapies and their transformative potential from bench to bed side with novel, highly effective, and clinical safety.Keywords
This publication has 174 references indexed in Scilit:
- Mitochondrial‐Targeted Copper Delivery for Cuproptosis‐Based Synergistic Cancer TherapyAdvanced Healthcare Materials, 2024
- Design of Near Infrared Light‐Powered Copper Phyllosilicate Nanomotors for Cuproptosis‐Based Synergistic Cancer TherapyAdvanced Functional Materials, 2024
- Engineered Microbial Nanohybrids for Tumor‐Mediated NIR II Photothermal Enhanced Ferroptosis/Cuproptosis and ImmunotherapyAdvanced Healthcare Materials, 2023
- Redox Homeostasis Disruptors Based on Metal‐Phenolic Network Nanoparticles for Chemo/Chemodynamic Synergistic Tumor Therapy through Activating Apoptosis and CuproptosisAdvanced Healthcare Materials, 2023
- H2S‐Activated Ion‐Interference Therapy: A Novel Tumor Targeted Therapy Based on Copper‐Overload‐Mediated Cuproptosis and PyroptosisAdvanced Functional Materials, 2023
- Biodegradable CuMoO4 Nanodots with Multienzyme Activities for Multimodal Treatment of TumorAdvanced Healthcare Materials, 2023
- Cuproptosis‐Driven Enhancement of Thermotherapy by Sequentially Response Cu2‐xSe via Copper Chemical TransitionAdvanced Functional Materials, 2023
- Tumor Microenvironment Responsive Hollow Nanoplatform for Triple Amplification of Oxidative Stress to Enhance Cuproptosis‐Based Synergistic Cancer TherapyAdvanced Healthcare Materials, 2023
- A Hollow Amorphous Bimetal Organic Framework for Synergistic Cuproptosis/Ferroptosis/Apoptosis Anticancer Therapy via Disrupting Intracellular Redox Homeostasis and Copper/Iron MetabolismsAdvanced Functional Materials, 2022
- Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7AMolecular Oncology, 2021